Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0000950170-25-004923

Options or other derivatives

  • Chief Executive Officer acquired 666,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gros David-Alexandre C · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-01-10 Grant or award : show line 1 in the form Stock Option (right to buy) +600,000 600,000 D
2025-01-10 Grant or award : show line 2 in the form Restricted Stock Units +66,500 66,500 D
Loading xslF345X05/ownership.xml…